{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:55:49Z","timestamp":1758981349419},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.013","type":"journal-article","created":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T06:49:23Z","timestamp":1224830963000},"page":"99-106","source":"Crossref","is-referenced-by-count":23,"title":["DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB\/c mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Sami Ben Hadj","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Touihri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yessine","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koussay","family":"Dellagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chokri","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2008.10.013_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2008.10.013_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/000349803225002516","article-title":"HIV and the transmission of Leishmania","volume":"97","author":"Molina","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.013_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.10.013_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccine: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2008.10.013_bib5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0264-410X(94)90079-5","article-title":"Genetic vaccination against leishmaniasis","volume":"12","author":"Xu","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.013_bib6","first-page":"173","article-title":"Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major","volume":"84","author":"Xu","year":"1995","journal-title":"Immunology"},{"issue":"13","key":"10.1016\/j.vaccine.2008.10.013_bib7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoptotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of Leishmaniasis","volume":"9","author":"Walker","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.10.013_bib8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0264-410X(01)00427-3","article-title":"A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36\/LACK antigen protects BALB\/c mice from cutaneous leishmaniasis","volume":"20","author":"Gonzalo","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.013_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2008.10.013_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.013_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2008.10.013_bib12","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"Sobie","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"10.1016\/j.vaccine.2008.10.013_bib13","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(00)00109-2","article-title":"Therapy of murine cutaneous leishmaniasis by DNA vaccination","volume":"18","author":"Handman","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.013_bib14","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","article-title":"Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB\/c mice","volume":"70","author":"Campos-Neto","year":"2002","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.10.013_bib15","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.013_bib16","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/IAI.71.11.6562-6572.2003","article-title":"The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB\/c mice","volume":"71","author":"Iborra","year":"2003","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.013_bib17","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.71.11.6270-6278.2003","article-title":"DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis","volume":"71","author":"Campbell","year":"2003","journal-title":"Infect Immun"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2008.10.013_bib18","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/S0264-410X(02)00354-7","article-title":"Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine","volume":"20","author":"Serezani","year":"2002","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.10.013_bib19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0264-410X(02)00352-3","article-title":"Vaccination with DNA encoding with ORFF antigen confers protective immunity in mice infected with Leishmania donovani","volume":"21","author":"Sukumaran","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.013_bib20","first-page":"135","article-title":"Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana","volume":"104","author":"Dumonteil","year":"2000","journal-title":"Dev Biol (Basel)"},{"issue":"16","key":"10.1016\/j.vaccine.2008.10.013_bib21","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.vaccine.2006.01.030","article-title":"Comparison of potential protection induced by three vaccination strategies (DNA\/DNA, Protein\/Protein and DNA\/Protein) against Leishmania major infection using Signal Peptidase type I in BALB\/c mice","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.013_bib22","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.013_bib23","first-page":"90520","article-title":"DNA vaccines against protozoan parasites: advances and challenges","volume":"2007","author":"Dumonteil","year":"2007","journal-title":"J Biomed Biotechnol"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2008.10.013_bib24","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/S0264-410X(02)00376-6","article-title":"Optimization of DNA vaccination against cutaneous leishmaniasis","volume":"20","author":"Mendez","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.013_bib25","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and non human primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2008.10.013_bib26","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2004.04.015","article-title":"Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniasis","volume":"22","author":"Iborra","year":"2004","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2008.10.013_bib27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.vaccine.2003.10.046","article-title":"A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major","volume":"22","author":"Ben Hadj Ahmed","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.013_bib28","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/IAI.69.8.4906-4915.2001","article-title":"Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response","volume":"69","author":"Kebaier","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2008.10.013_bib29","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania major in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"46","key":"10.1016\/j.vaccine.2008.10.013_bib30","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1016\/j.vaccine.2007.08.023","article-title":"Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge","volume":"25","author":"Rodriguez-Cor\u00e9s","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.013_bib31","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.013_bib32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.vaccine.2005.10.052","article-title":"Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs","volume":"24","author":"Saldarriaga","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.013_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.185.3.373","article-title":"Multiple pathways for the initiation of T helper 2 (Th2) responses","volume":"185","author":"Coffman","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.013_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11101.x","article-title":"Type 1 and Type 2 responses to Leishmania major","volume":"209","author":"Rogers","year":"2002","journal-title":"FEMS Microbiol Lett"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.013_bib35","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with polyprotein vaccine consisting of the T-cell antigens Thiol-specific antioxidant, Leishmania major Stress-Inducible protein 1, and Leishmania Elongation Initiation Factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2008.10.013_bib36","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.013_bib37","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2008.10.013_bib38","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant parasite surface antigen 2 from leishmania major induces a th1 type of immune response but does not protect against infection","volume":"16","author":"Sj\u00f6lander","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.013_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00436-005-0008-8","article-title":"Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-gamma production but does not protect BALB\/c mice against Leishmania chagasi intravenous challenge","volume":"98","author":"Marques-da-Silva","year":"2005","journal-title":"Parasitol Res"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.013_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ni1102-1041","article-title":"Evasion of innate immunity by parasitic protozoa","volume":"3","author":"Sacks","year":"2002","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.013_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T18:20:08Z","timestamp":1545675608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08013923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08013923"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}